New study combines skin scans and DNA to catch melanoma earlier

NCT ID NCT07277920

Recruiting now Knowledge-focused Sponsor: University of Modena and Reggio Emilia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 200 people with suspicious moles that are already scheduled for removal. Researchers will use a special microscope (reflectance confocal microscopy) to take detailed images of the moles and then compare those images with genetic tests from the removed tissue. The goal is to find patterns that help tell harmless moles from early melanomas, which could lead to faster and more accurate diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better, non-invasive tools for spotting early melanoma and reduce unnecessary biopsies.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change patient care, and results might not apply to all skin types or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL MELANOCYTIC LESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanocytic nevus melanoma neutrophil actin dysfunction Nevus, Pigmented

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOCYTIC NEVI MELANOMA (SKIN CANCER) NEXT GENERATION SEQUENCING (NGS)

Contacts and locations

Locations

Dermatology Department, University Hospital of Modena
RECRUITING

Modena, Mo, 41125, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.